Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06401785
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-02-18
Brief Title:
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Sponsor:
HoHo Biotech
Organization:
HoHo Biotech
Study Overview
Official Title:
To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The supplementation of hydrogen molecules as an aid adjuvant may speed up recovering the course of the disease The purpose of this study is to determine the possible efficacy and safety of solid hydrogen supplements for a clinical study in patients with chronic diseases Patients will receive hydrogen capsules with their conventional treatment for 24 weeks Investigators will test for any changes in haematologic urine analysis and health status during and following the exposure period
Detailed Description:
Hydrogen supplement has been shown to have significant removing effects on free radicals International clinical trials have shown promise that hydrogen molecules may reduce chronic inflammatory and then speed up recovering the course of the diseaseThe purpose of this study is to determine the possible efficacy and safety of hydrogen supplements in different formula and dose exposures for a clinical study in patients with chronic diseasesStudy design 60 chronic diseases patients will be recruited from the Taoyuan Armed Forces General Hospital and Tri-Service General Hospital for this study Participants will be screened by doctors for their eligibility and undergo a series of tests questionnaires and examinationsConsenting participants will then be randomly allocated into 2 groups experiment group and control group single-blind study In experiment group participants will receive 2 solid hydrogen capsules every day for 24 weeks In control group participants will receive 2 capsules not containing hydrogen every day for 24 weeks Participants will be examined their regular haematology urine and health status before and after the intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None